Search research articles
Contact Us
Filters
Showing results (231-240 of 548) with videos related to
Page
of 55
Sort By:
European Journal of Pharmacology
|
May 2, 1980
Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration
A Clow, A Theodorou, P Jenner, et al.
Neurology
|
April 1, 1981
Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors
H Kolbe, A Clow, P Jenner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 2, 2011
Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression
P Jenner, A C McCreary, D K A Scheller
Lancet (London, England)
|
April 28, 1979
Neuroleptic drugs and the dopamine hypothesis
A Clow, P Jenner, A Theodorou, et al.
Advances in Neurology
|
January 1, 1986
Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder
D Chadwick, M Hallett, P Jenner, et al.
Advances in Neurology
|
January 1, 1987
MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects
P Jenner, S Rose, M Nomoto, et al.
Neuroscience Letters
|
May 1, 1979
Turning behaviour induced by injection of muscimol or picrotoxin into the substantia nigra demonstrates dual GABA components
C Reavill, P Jenner, N Leigh, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 27, 2003
Inhibition of neuronal nitric oxide synthase increases dopamine efflux from rat striatum
M T Silva, S Rose, J G Hindmarsh, et al.
Life Sciences
|
December 7, 1981
Drug-induced circling after unilateral 6-hydroxydopamine lesions of the nigro-striatal pathway is mediated via the midbrain periaqueductal grey and adjacent reticular formation (angular complex)
C Reavill, P N Leigh, P Jenner, et al.
Advances in Neurology
|
January 1, 1993
Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia
D T Dexter, J Sian, P Jenner, et al.
Page
of 55
Search research articles
Search
Showing results (231-240 of 548) with videos related to
Sort By:
Page
of 55
European Journal of Pharmacology
|
May 2, 1980
Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration
A Clow, A Theodorou, P Jenner, et al.
Neurology
|
April 1, 1981
Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors
H Kolbe, A Clow, P Jenner, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 2, 2011
Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression
P Jenner, A C McCreary, D K A Scheller
Lancet (London, England)
|
April 28, 1979
Neuroleptic drugs and the dopamine hypothesis
A Clow, P Jenner, A Theodorou, et al.
Advances in Neurology
|
January 1, 1986
Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder
D Chadwick, M Hallett, P Jenner, et al.
Advances in Neurology
|
January 1, 1987
MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects
P Jenner, S Rose, M Nomoto, et al.
Neuroscience Letters
|
May 1, 1979
Turning behaviour induced by injection of muscimol or picrotoxin into the substantia nigra demonstrates dual GABA components
C Reavill, P Jenner, N Leigh, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 27, 2003
Inhibition of neuronal nitric oxide synthase increases dopamine efflux from rat striatum
M T Silva, S Rose, J G Hindmarsh, et al.
Life Sciences
|
December 7, 1981
Drug-induced circling after unilateral 6-hydroxydopamine lesions of the nigro-striatal pathway is mediated via the midbrain periaqueductal grey and adjacent reticular formation (angular complex)
C Reavill, P N Leigh, P Jenner, et al.
Advances in Neurology
|
January 1, 1993
Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia
D T Dexter, J Sian, P Jenner, et al.
Page
of 55